Evommune, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | — | $-77.7M | $29.2M |
| FY2024 | — | $-144.2M | $16.3M |
| FY2025 | — | $205.6M | $44.1M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | — | $-77.7M | $29.2M |
| FY2024 | — | $-144.2M | $16.3M |
| FY2025 | — | $205.6M | $44.1M |